1NAGHAVI M, LIBBY P, FALK E,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies[J]. Cireulation , 2003 , 108: 1664-1672.
2LUND J, QIN Q P, ILVA T, et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin Ⅰ elevation[J]. Circulation, 2003,21, 108: 1924-1926.
3WU A H. The ischemia modified albumin biomarker for myocardial ischemia [J]. MLO Med Lab Obs,2003 , 35:36-38, 40.
4LAWRENCE J B, OXVIG C, OVERGAARD M T,et al. The insulin-like growth factor(IGF)-depcndent IGF protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A[J]. Proc Natl Acad Sci USA , 1999, 96:3149-3153.
5BAYES-GENIS A, CONOVER C A, OVERGAARDM T, et al. Pregnancy associated plasma protein A as a marker of acute coronary syndromes[J]. N Engl J Med, 2001, 345: 1022-1029.
6KHOSRAVI J, DIAMANDIA A, KRISHNAB R G,et al. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease[J]. Clin Biochem ,2002, 35:531-538.
7POPKEN-HARRIS P, CHECKEL J , LOEGERING K, et al. Regulation and processing of a precursor form of eosinophil granule major basic protein (ProMBP) in differentiating eosinophils[J]. Blood, 1998,92: 623-631.
8SILAHAROGLU A N, TUMER Z, KRISTENSENT, et al. Assignment of the human gene for proegnancy-assoicated plasma protein A(PAPPA) to 9q33.1 by fluorescence in situ hybridization to mitotic and meiotic chromosomes [J]. Cytogenet Cell Genet,1993, 62:214-216.
9HANING J, OXVIG C, OVERGAARD M T, et al.Complete cDNA sequence of the preproform of human pregnancy-associated plasma protein-A. Evidence for expression in the brain and induction by cAMP[J].Eur J Biochem, 1996, 237: 159-163.
10STOCKER W, GRAMS F, BAUMANN U, et al.The metzincins: topological and sequential relations between the astacins , adamalysins , serralysins, and matrixins (collagenases) define a superfamily of zincpeptidases[J]. Protein Sci, 1995, 4:823-840.
3Boyle JJ.Macrophage activation in atherosclerosis:pathogenesis and pharmacology of plaque rapture[J].Curr Vasc Pharmacol,2005,3(1):63-68.
4Saam T,Hatsukami TS,Takaya N,et al.The vulnerable,or high-rlsk,atherosclerotic plaque:noninvasive MR imaging for characterization and assessment[J].Radiology,2007,244(1):64-77.
5Kinlay S,Egido J.Inflammatory biomarkers in stable atherosclerosis[J].Am J Cardiol,2006,98(11A):2-8.
6Packard RR,Libby P.Inflammation in atherosclerosis:from vascular biology to biomarker discovery and risk predictio[J].Clin Chem,2008,54(1):24-38.
7Ferri C,Croce G,Cofini V,et al.C-reactive protein:interaction with the vascular endothelium and possible role in human atherosclerosis[J].Curr Pharm Des,2007,13(16):1631-1645.
8Burke AP,Tracy RP,Kolodgie F,et al.Elevated Creactive protein values and atherosclerosis in sudden coronary death:association with different pathologies[J].Circulation,2002,105 (17):2019-2023.
9Koenig W,Khuseyinova N.Biomarkers of atherosclerotic plaque instability and rupture[J].Arterioscler Thromb Vase Biol,2007,27(1):15-26.
10Virani SS,Polsani VR,Nambi V.Novel markers of inflammation in atherosclerosis[J].Curr Atheroscler Rep,2008,10(2):164-170.
